Management's Discussion and Analysis of Financial Condition
and Results of Operations
The Gillette Company and Subsidiary Companies
RESULTS OF OPERATIONS
Discontinued Operations
Effective June 30, 2000, the Company decided to sell the Stationery Products
business. As a result, this business is accounted for as a discontinued
operation in the financial statements. The sale of the business to Newell
Rubbermaid Inc. was finalized on December 29, 2000. The after-tax loss on the
disposal of the business was $428 million, and the after-tax loss from
discontinued operations, up to the measurement date of June 30, 2000, was $1
million. The loss on the disposal of the business includes a charge for direct
transaction costs, employee severance, assets not transferable and disposed of
and for other employee benefits, including fringe benefits, outplacement fees
and special termination benefits related to pensions. Additional details are
provided in the Notes to Consolidated Financial Statements.
Net Sales
Net sales from continuing operations in 2000 were $9.30 billion, 2% above those
of 1999. Excluding the adverse effects of exchange, 5%, and the divestiture of
the White Rain hair care line, 1%, sales climbed 8%. The 8% sales growth was
attributable to favorable volume/mix of 6% and pricing of 2%, as increased
marketing support contributed to good volume growth across all categories,
except Duracell. Net sales in 1999 were $9.15 billion, essentially even with
those of 1998. Pricing contributed 3% and volume/mix 1%, favorable factors that
were offset by 4% unfavorable exchange. Excluding the adverse effects of
exchange and the 1998 divestiture of Jafra Cosmetics International, sales rose
5%.
An analysis of sales by business segment for continuing operations follows.
(Millions) % Increase/(Decrease)
-------------------------- ---------------------
2000 1999 1998 00/99 99/98
- --------------------------------------------------------------------------------
Blades & Razors $3,407 $3,167 $3,028 8 5
Toiletries 978 1,062 1,214 (8) (13)
Duracell Products 2,577 2,726 2,576 (5) 6
Oral-B Products 676 616 642 10 (4)
Braun Products 1,657 1,583 1,740 5 (9)
--------------------------------------------------
$9,295 $9,154 $9,200 2 --
==================================================
See Notes to Consolidated Financial Statements for segment data.
Sales of blades and razors were 8% higher than those of the prior year, due
primarily to strong sales of the Mach3 shaving system in North America, Europe
and Latin America. In Europe, sales were aided by a 39% increase in Mach3
cartridge shipments. Sales in Latin America were boosted by the successful
launch of the Mach3 system in Brazil. In 1999, blade and razor sales were 5%
above those of a year earlier, buoyed by the Mach3 shaving system, which was
launched in all major markets, except Brazil, by year-end 1999. Sales in North
America, reflecting the steady growth of the Mach3 system, were 14% above those
of 1998. The Company's trade inventory reduction initiative contributed to lower
sales in Europe and Latin America.
Toiletries sales were 8% below those of the prior year, due primarily to
the divestiture of the White Rain brand in April 2000. Sales of pre- and
post-shave products were 6% above those of the year before. In 1999, toiletries
sales were 13% below those of the previous year, due in part to the divestiture
of the Jafra business in April 1998. Excluding Jafra, toiletries sales declined
7%.
Sales of Duracell products declined 5%, as a 37% increase in sales of
Duracell Ultra batteries was more than offset by lower sales of both Copper &
Black and non-Duracell branded batteries. Contributing to the lower sales were
increased competition faced by the Copper & Black brand in North America,
depreciation of the Euro and lower overall battery sales in Korea, as well as
low-priced alkaline competition in China. In 1999,
17
sales of Duracell products rose 6%, led by a 15% sales gain in North America
that reflected improved volume/mix in a period of heightened consumer activity
due to Year 2000 concerns. Higher volume in the AMEE region and better mix in
the Asia-Pacific region also contributed to the increase in Duracell sales in
1999.
Sales of Oral-B products were 10% above those of 1999. Sales growth, which
was achieved in all geographies except Europe, was paced by Latin America, where
economic conditions improved and the rollout of the premium CrossAction
toothbrush to the region's largest markets was completed. In North America,
sales growth also reflected new product activity, including the third-quarter
launch of the Oral-B Advantage Plus toothbrush. In 1999, sales of Oral-B
products were 4% below those of a year earlier. Gains in North America, driven
by the success of the CrossAction toothbrush, were more than offset by
shortfalls in Latin America that resulted from the region's economic weakness.
Braun sales rose 5% from those of 1999. Aided by broad-based advertising
support for core product categories, sales increases were achieved across all
geographies except Europe, where sales were restrained by the depreciation of
the Euro. Sales of the Braun Syncro electric shaver drove growth in Germany and
Japan, while improving economic conditions and increased distribution led to
strong advances in the AMEE region and Latin America. Sales in 1999 were 9%
below those of the year before, due to economic softness in Europe and lower
sales in North America.
Gross Profit
Gross profit from continuing operations was $5.91 billion in 2000, $5.76 billion
in 1999 and $5.70 billion in 1998. As a percent of sales, gross profit was 63.6%
in 2000, compared with 62.9% in 1999 and 62.0% in 1998. Margin improvement in
both years was due to several factors: favorable sales mix; continued
manufacturing efficiencies; and the benefit to our product cost structure of
savings from the 1998 reorganization and realignment program.
Selling, General and Administrative Expenses
Selling, general and administrative expenses from continuing operations amounted
to 41.2% of sales, compared with 40.1% and 37.9% in 1999 and 1998, respectively.
In absolute terms, these expenses increased 4% in 2000 and 5% in 1999. In 2000,
$608 million was spent on advertising, including sampling, and $1,268 million on
sales promotion, for a total of $1,876 million, an increase of 12% over the 1999
spending level. This spending compares with 1999 amounts of $580 million, $1,087
million and $1,667 million, respectively. In 1998, these amounts were $593
million, $1,055 million and $1,648 million, respectively. The spending in 2000
represented 20.2% of sales, compared with 18.2% and 17.9% in 1999 and 1998,
respectively. Other operating expenses declined 3% in 2000, reflecting a full
year of benefits from the reorganization and realignment program, and increased
9% in 1999.
Profit from Operations
Profit from continuing operations was $1.51 billion in 2000, compared with $2.09
billion in 1999 and $1.78 billion in 1998. Profit from operations in 2000 was
$2.08 billion before a restructuring and asset impairment charge of $572
million. Profit from operations in 1998 was $2.22 billion before a
reorganization and realignment charge of $440 million. Profit from operations in
2000 represented 22.4% of sales, compared with 22.8% in 1999 and 24.1% in 1998,
excluding the restructuring and asset impairment charge in 2000 and the
reorganization and realignment charge in 1998. Operating profits in 2000 were
almost even with those of 1999, as improved gross profit margin and cost savings
from other operating expenses were offset by significant increases in marketing
expenses. The decrease in operating profits in 1999 was due to a $30 million
increase in marketing support and a $14 million increase in research and
development for new product programs. Further, the Company incurred $61 million
of incremental expenses related to the reorganization and realignment program,
primarily for equipment and employee relocation and training. These expenses
were not included as part of the original reserve, due to the requirements of
the accounting standards. In addition, a gain of $22 million on the sale of land
and a building was recognized in 1999.
In the following table, the 2000 restructuring and asset impairment charge
and the 1998 reorganization and realignment charge are included in
Corporate/Other.
18
An analysis of operating profit by business segment for continuing operations
follows.
(Millions) % Increase/(Decrease)
-------------------------- ---------------------
2000 1999 1998 00/99 99/98
- --------------------------------------------------------------------------------
Blades & Razors $1,340 $1,206 $1,153 11 5
Toiletries 76 85 54 (11) 57
Duracell Products 439 606 597 (28) 2
Oral-B Products 75 77 101 (3) (24)
Braun Products 218 154 291 41 (47)
--------------------------------------------------
$2,148 $2,128 $2,196 1 (3)
--------------------------------------------------
Corporate/Other (636) (41) (420)
--------------------------
$1,512 $2,087 $1,776
==========================
See Notes to Consolidated Financial Statements for segment data.
Blade and razor profits were 11% higher in 2000, due primarily to the sales
growth of the Mach3 shaving system in North America, Europe and Latin America.
Blade and razor profits were 5% higher in 1999, due to the sales growth of the
Mach3 shaving system.
Toiletries profits were 11% below those of the prior year, in line with
lower sales. Toiletries profits in 1999 were 57% above those of the previous
year, due to unmatched new product launch expenses in 1998.
Duracell profit from operations was 28% below that of the year before,
reflecting both lower sales and increased marketing spending and related
strategic actions in North America designed to regain market share, restore
growth momentum and increase profitability. In 1999, Duracell reported profits
2% above those of the previous year, reflecting higher marketing expenses behind
the geographic rollout of Duracell Ultra batteries and increased promotional
support in North America.
Oral-B profit from operations was 3% below that of 1999, due primarily to
higher marketing expenses to support new product launches. In 1999, Oral-B
profits declined 24%, due to marketing expenses supporting the CrossAction
toothbrush launch in North America and Europe.
Braun profit from operations was 41% above that of 1999, reflecting sales
growth, improved mix and lower overhead expenses. Braun profits were $154
million in 1999, compared with $291 million in 1998, primarily the result of
lower revenue to cover fixed costs.
Nonoperating Charges/Income
Net interest expense amounted to $218 million in 2000, $129 million in 1999 and
$86 million in 1998. Net interest expense rose in 2000, reflecting increased
borrowings to fund the share repurchase program and higher interest rates. Net
interest expense rose in 1999, due to higher borrowings to fund the Company's
share repurchase program. A net exchange gain of $8 million in 2000, which
compared with 1999 and 1998 losses of $35 million and $23 million, respectively,
was due primarily to subsidiaries in highly inflationary countries. Translation
adjustments resulting from currency fluctuations of net foreign investments in
non-highly inflationary countries are accumulated in a separate section of
stockholders' equity, as noted on page 30. In 2000, the unfavorable translation
adjustment was $249 million, compared with $205 million in 1999 and $36 million
in 1998, reflecting significant exchange rate movements.
Taxes and Income From Continuing Operations
The effective tax rate was 36.3% in 2000, compared with rates of 34.8% in 1999
and 35.3% in 1998. The effective tax rate increased in 2000, due to the
nondeductibility of certain asset impairment charges. Excluding the impact of
these nondeductible charges, the tax rate declined to 32.8%. The decrease was
primarily attributable to the reduction of the tax rate in Germany and the
Company's tax management strategies.
Income from continuing operations was $821 million in 2000, compared with
$1,248 million in 1999 and $1,073 million in 1998. Fully diluted net income per
common share from continuing operations was $.77 in 2000, compared with $1.13
and $.94 in 1999 and 1998, respectively.
Excluding the charges in 2000 for restructuring and asset impairment and
in 1998 for reorganization and realignment, income from continuing operations
was $1,251 million in 2000, compared with $1,248 million in 1999 and $1,358
million in 1998. Fully diluted net income per common share from continuing
operations was $1.18 in 2000, compared with $1.13 and $1.19 in 1999 and 1998,
respectively.
19
Financial Condition
The Company's financial condition continued to be strong in 2000. Net debt
(total debt net of associated swaps, less cash and cash equivalents) decreased
$82 million during 2000, despite additional spending under the Company's share
repurchase program, due to improved cash flow from operations, proceeds from the
sale of the Stationery Products business and the favorable exchange impact on
foreign currency debt. Net debt at December 31, 2000, amounted to $4.45 billion,
compared with $4.53 billion and $3.18 billion at December 31, 1999 and 1998,
respectively. The market value of Gillette equity was $38 billion at the end of
2000, compared with $43 billion at the end of 1999. The Company's book equity
position amounted to $1.92 billion at the end of 2000, compared with $3.06
billion at the end of 1999 and $4.54 billion at the end of 1998. The decreases
in book equity in 2000 and 1999 were due primarily to the Gillette share
repurchase program, as well as to the effect of foreign currency translation.
Net cash provided by operating activities in 2000 was $1.60 billion,
compared with $1.43 billion in 1999 and $.96 billion in 1998. The current ratio
of the Company was .86 for 2000, compared with ratios of 1.39 for 1999 and 1.40
for 1998. The decrease in the 2000 current ratio was primarily attributable to
the Company's reclassification of all commercial paper borrowings to short-term
debt, due to the Company's credit facility agreements expiring within 2001.
Capital spending in 2000 amounted to $793 million, compared with $889 million in
1999 and $952 million in 1998. Spending in all three years reflected substantial
investments in the blade and razor, Duracell and Braun Products segments.
In 2000, the Company sold the Stationery Products business for $528
million. In 1998, the Company made acquisitions in the Duracell Products segment
for $100 million and sold the Jafra business for $200 million.
Share repurchase funding in 2000, net of proceeds received from the sale
of put options on Company stock, amounted to $921 million, compared with $1,949
million in 1999 and $1,010 million in 1998.
Strong cash inflows from operations, proceeds from the sale of the
Stationery Products business and alternate financing sources enabled the Company
to reduce its $2.0 billion revolving credit facility in 2000 to $1.4 billion,
expiring October 2001, and its $1.1 billion credit facility, expiring December
2001, to $550 million in January 2001. Both facilities are used by the Company
to complement its commercial paper program.
In order to increase flexibility in sourcing short-term borrowing, the
Company launched a $1 billion Euro commercial paper program in 2000. At year-end
2000, there was $586 million outstanding under this program and $1.45 billion
outstanding under the U.S. program, compared with $2.41 billion at the end of
1999 and $1.66 billion at the end of 1998.
During 2000, the Company issued Euro-denominated notes for $228 million,
due December 2002, and entered into a $264 million Euro-denominated debt
obligation, with redemption rights in December 2001. During 1999, the Company
issued Euro-denominated notes for $343 million, due February 2004, and entered
into a $325 million Euro-denominated debt obligation, with redemption rights in
March 2002, and a $437 million Euro-denominated debt obligation, with redemption
rights in January 2003. The net proceeds were used to refinance existing
short-term debt associated with the Company's share repurchase program.
During 2000, both Standard & Poor's and Moody's maintained the Company's
current credit ratings. Standard & Poor's rates the Company's long-term debt at
AA, while Moody's rating is Aa3. The commercial paper rating is A1+ by Standard
& Poor's and P1 by Moody's.
Gillette will continue to have capital available for growth through both
internally generated funds and significant credit resources. The Company has
substantial unused lines of credit and access to worldwide financial market
sources for funds.
Market Risk
The Company is subject to currency and interest rate risks that arise from
normal business operations. The Company regularly assesses these risks and has
established business strategies that offset exposures, supplemented by the use
of financial instruments, to protect against the adverse effects of these and
other market risks.
To manage the impact of currency changes on foreign-denominated profits,
the Company primarily uses product sourcing and pricing strategies, supplemented
by purchases of foreign currency options when considered appropriate.
The Company uses foreign-denominated debt and forward contracts to hedge
the impact of currency changes on its net foreign investments, normally in
currencies with low interest rates.
20
Most of the Company's transactional exchange exposure is concentrated
through centralized cash management and intercompany invoicing. The Company
hedges net residual transactional exchange exposures primarily through forward
contracts.
The Company uses primarily floating rate debt in order to match interest
costs to the impact of inflation on earnings. The Company manages its mix of
fixed and floating rate debt by entering into interest rate swaps.
More detailed information about the strategies, policies and use of
derivative financial instruments is provided in the financial instruments note.
The Company has established clear policies, procedures and internal controls
governing the use of derivative financial instruments and does not use them for
trading, investment or other speculative purposes. Financial instrument
positions are monitored using a value-at-risk model. Value at risk is estimated
for each instrument based on historical volatility of market rates and a 95%
confidence level.
Based on the Company's overall evaluation of its market risk exposures
from all of its financial instruments at December 31, 2000 and 1999, a near-term
change in market rates would not materially affect the consolidated financial
position, results of operations or cash flows of the Company.
Restructuring and Asset Impairments
On December 18, 2000, the Company announced a restructuring program and impaired
certain intangible assets. This resulted in a fourth-quarter charge to
operations of $572 million ($430 million after taxes, or $.41 in net income per
common share, fully diluted).
The worldwide restructuring of operations is expected to significantly
improve the Company's operating efficiency, streamline the supply chain and
further decrease costs. The program will result in a net reduction of
approximately 2,700 employees across all business functions, operating units and
geographies.
Pretax cash outlays are estimated at approximately $235 million. Cash
severance payments may extend beyond 2001, due to the severance payment deferral
options available to terminated employees. When the program is fully implemented
by the end of 2001, the annual pretax savings will approximate $125 million.
Specific program activities include consolidating management functions;
reducing factory locations, in part through outsourcing production of low-volume
noncore products; streamlining the supply chain via warehouse consolidation and
other actions; and downsizing and centralizing corporate functions. These
actions will result in the closure of eight factories and 13 distribution
centers and will be completed within 12 months.
The amount of impairment is approximately $125 million for the
restructuring and closure of factories and distribution centers, as well as the
write-off of manufacturing, distribution and office equipment assets. Until the
affected facilities cease operations, revenue-generating activities will
continue. Buildings that are owned will be sold, and equipment will be disposed
of through either sale or abandonment. The extent of the impairment was based on
discounted cash flow analyses for the operating period up until closure and
included an estimate of residual value.
In addition, the charge included $212 million for the write-down of
impaired goodwill relating to certain underperforming brands. This write-down
was determined based upon a year-end impairment analysis necessitated by new
evidence that indicated that the carrying amounts of the assets relating to the
Thermoscan personal diagnostic appliance brand and certain national battery
brands might not be fully recovered through undiscounted future operating cash
flows. Such analysis indicated that impairment existed equivalent to the
carrying amount of the acquired goodwill for one brand in the Braun Products
segment, and the carrying amount of the acquired goodwill and identifiable
intangible assets for certain brands in the Duracell Products segment. This
analysis did not indicate impairment of the carrying amounts of any related
tangible long-lived assets associated with these underperforming brands.
Additional details are provided in the Notes to Consolidated Financial
Statements.
21
Reorganization and Realignment
On September 28, 1998, the Company announced a reorganization and realignment
program that resulted in a third-quarter charge to operations, for the total
program, of $535 million ($347 million after taxes, or $.30 income per common
share, fully diluted). For continuing operations, the charge to operations was
$440 million ($285 million after taxes, or $.25 in net income per common share,
fully diluted).
The total program resulted in the closure of 14 factories, 13 warehouses
and 34 office facilities, as well as a reduction of 4,623 employees across all
business segments, geographies and employee groups. Activity in 2000 consisted
of the closing of three factories, two warehouses and five office facilities, as
well as a reduction of 1,173 employees. Project activity was essentially
complete at March 31, 2000.
Pretax cash outlays were $16 million in 1998, $197 million in 1999 and
$113 million in 2000. Cash severance payments extended beyond the completion of
program activities, due to the severance payment deferral options available to
terminated employees. In 2000, cash benefits generated from the program were in
line with original estimates.
Additional reorganization and realignment details are provided in the
Notes to Consolidated Financial Statements.
Euro Conversion
A multifunctional Euro project team is responsible for ensuring the Company's
ability to operate effectively during the Euro transition phase and through
final Euro conversion. Total program costs are not expected to be material.
Among other factors, conversion to the Euro may affect competition between
markets, due to the existing pricing structure. The Company has developed
marketing and pricing strategies for implementation throughout the more open
European market. The Euro project team will further enhance these strategies as
part of the ongoing Euro initiative. The Company is currently able to make and
receive payments in Euros and will convert financial and information technology
systems to be able to use Euros as its base currency in relevant markets prior
to January 1, 2002. Based on the analysis and actions taken to date, the Company
does not expect the Euro conversion to materially affect the consolidated
financial position, results of operations or cash flows of the Company.
RESPONSIBILITY FOR FINANCIAL STATEMENTS
The Company is responsible for the objectivity and integrity of the accompanying
consolidated financial statements, which have been prepared in conformity with
accounting principles generally accepted in the United States. The financial
statements of necessity include the Company's estimates and judgments relating
to matters not concluded by year-end. Financial information contained elsewhere
in the 2000 Annual Report and Form 10-K is consistent with that included in the
financial statements.
The Company maintains a system of internal accounting controls that
includes careful selection and development of employees, division of duties, and
written accounting and operating policies and procedures augmented by a
continuing internal audit program. Although there are inherent limitations to
the effectiveness of any system of accounting controls, the Company believes
that its system provides reasonable, but not absolute, assurance that its assets
are safeguarded from unauthorized use or disposition and that its accounting
records are sufficiently reliable to permit the preparation of financial
statements that conform in all material respects with accounting principles
generally accepted in the United States.
KPMG LLP, independent auditors, are engaged to render an independent
opinion regarding the fair presentation in the financial statements of the
Company's financial condition and operating results. Their report appears on
page 23. Their examination was made in accordance with auditing standards
generally accepted in the United States and included a review of the system of
internal accounting controls to the extent they considered necessary to
determine the audit procedures required to support their opinion.
The Audit Committee of the Board of Directors is composed solely of
independent directors, as defined by the New York Stock Exchange. The Committee
meets periodically and privately with the independent auditors, internal
auditors and financial officers of the Company, as it deems necessary, to review
the quality of the financial reporting of the Company, the internal accounting
controls and the scope and results of audit examinations. The Committee also
reviews compliance with the Company's policies relating to proper accounting and
financial reporting systems and the independence of the independent auditors. In
addition, the Committee is responsible for recommending the appointment of the
Company's independent auditors.
22
Independent Auditors' Report
The Gillette Company and Subsidiary Companies
[KPMG LOGO]
The Stockholders and Board of Directors of The Gillette Company
We have audited the accompanying consolidated balance sheet of The Gillette
Company and subsidiary companies as of December 31, 2000 and 1999, and the
related consolidated statements of income, cash flows and stockholders' equity
for each of the years in the three-year period ended December 31, 2000. These
consolidated financial statements are the responsibility of the Company's
management. Our responsibility is to express an opinion on these consolidated
financial statements based on our audits.
We conducted our audits in accordance with auditing standards generally
accepted in the United States of America. Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audits provide a
reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above
present fairly, in all material respects, the financial position of The Gillette
Company and subsidiary companies as of December 31, 2000 and 1999, and the
results of their operations and their cash flows for each of the years in the
three-year period ended December 31, 2000, in conformity with accounting
principles generally accepted in the United States of America.
/s/ KPMG LLP
KPMG LLP
Boston, Massachusetts
February 12, 2001
23
Consolidated Statement of Income
The Gillette Company and Subsidiary Companies
Years Ended December 31, 2000, 1999 and 1998 2000 1999 1998
- ---------------------------------------------------------------------------------------
(Millions, except per share amounts)
Net Sales $9,295 $9,154 $9,200
Cost of Sales 3,384 3,392 3,499
--------------------------
Gross Profit 5,911 5,762 5,701
Selling, General and Administrative Expenses 3,827 3,675 3,485
Restructuring and Asset Impairment Charges 572 -- 440
--------------------------
Profit from Operations 1,512 2,087 1,776
Nonoperating Charges (Income)
Interest income (5) (7) (8)
Interest expense 223 136 94
Other charges - net 6 46 34
--------------------------
224 175 120
--------------------------
Income from Continuing Operations before Income Taxes 1,288 1,912 1,656
Income Taxes 467 664 583
--------------------------
Income from Continuing Operations 821 1,248 1,073
Loss on Disposal of Discontinued Operations, net of tax (428) -- --
Income (Loss) from Discontinued Operations, net of tax (1) 12 8
--------------------------
Net Income $ 392 $1,260 $1,081
==========================
Net Income (Loss) per Common Share, basic
Continuing Operations $ .78 $ 1.14 $ .95
Disposal of Discontinued Operations (.41) -- --
Discontinued Operations -- .01 .01
--------------------------
Net Income $ .37 $ 1.15 $ .96
==========================
Net Income (Loss) per Common Share, assuming full dilution
Continuing Operations $ .77 $ 1.13 $ .94
Disposal of Discontinued Operations (.40) -- --
Discontinued Operations -- .01 .01
--------------------------
Net Income $ .37 $ 1.14 $ .95
==========================
Weighted average number of common shares outstanding
Basic 1,054 1,089 1,117
Assuming full dilution 1,063 1,111 1,144
See accompanying Notes to Consolidated Financial Statements.
24
Consolidated Balance Sheet
The Gillette Company and Subsidiary Companies
December 31, 2000 and 1999 2000 1999
- -----------------------------------------------------------------------------------------
(Millions, except per share amount)
Assets
Current Assets
Cash and cash equivalents $ 62 $ 80
Trade receivables, less allowances: 2000 - $81; 1999 - $74 2,128 2,208
Other receivables 378 319
Inventories 1,162 1,392
Deferred income taxes 566 309
Other current assets 197 315
Net assets of discontinued operations 189 1,174
------------------
Total Current Assets 4,682 5,797
------------------
Property, Plant and Equipment, at cost less accumulated depreciation 3,550 3,467
Intangible Assets, less accumulated amortization 1,574 1,897
Other Assets 596 625
------------------
$10,402 $11,786
==================
Liabilities and Stockholders' Equity
Current Liabilities
Loans payable $ 2,195 $ 1,440
Current portion of long-term debt 631 358
Accounts payable and accrued liabilities 2,346 2,149
Income taxes 299 233
------------------
Total Current Liabilities 5,471 4,180
------------------
Long-Term Debt 1,650 2,931
Deferred Income Taxes 450 423
Other Long-Term Liabilities 767 795
Minority Interest 41 38
Contingent Redemption Value of Common Stock Put Options 99 359
Stockholders' Equity
8.0% Cumulative Series C ESOP Convertible Preferred,
without par value, Issued: 1999 - .1 shares -- 85
Unearned ESOP compensation -- (4)
Common stock, par value $1 per share
Authorized: 2,320 shares
Issued: 2000 - 1,365 shares; 1999 - 1,364 shares 1,365 1,364
Additional paid-in capital 973 748
Earnings reinvested in the business 5,853 6,147
Accumulated other comprehensive income
Foreign currency translation (1,280) (1,031)
Pension adjustment (34) (30)
Treasury stock, at cost:
2000 - 312 shares; 1999 - 299 shares (4,953) (4,219)
------------------
Total Stockholders' Equity 1,924 3,060
------------------
$10,402 $11,786
==================
See accompanying Notes to Consolidated Financial Statements.
25
Consolidated Statement of Cash Flows
The Gillette Company and Subsidiary Companies
Years Ended December 31, 2000, 1999 and 1998 2000 1999 1998
- --------------------------------------------------------------------------------------------
(Millions)
Operating Activities
Income from continuing operations $ 821 $ 1,248 $ 1,073
Adjustments to reconcile income to net cash provided
by operating activities:
Provision for restructuring and asset impairment 572 -- 440
Depreciation and amortization 535 464 421
Other 5 (7) (46)
Changes in assets and liabilities, excluding effects
of acquisitions and divestitures:
Accounts receivable (100) (48) (442)
Inventories 149 (140) (62)
Accounts payable and accrued liabilities (45) 65 72
Other working capital items (136) 97 (104)
Other noncurrent assets and liabilities (197) (252) (142)
Funding German pension plans -- -- (252)
-----------------------------
Net cash provided by operating activities 1,604 1,427 958
-----------------------------
Investing Activities
Additions to property, plant and equipment (793) (889) (952)
Disposals of property, plant and equipment 41 124 65
Acquisition of businesses, less cash acquired -- -- (91)
Sale of businesses 539 -- 200
Other (1) 2 5
-----------------------------
Net cash used in investing activities (214) (763) (773)
-----------------------------
Financing Activities
Purchase of treasury stock (944) (2,021) (1,066)
Proceeds from sale of put options 23 72 56
Proceeds from exercise of stock option and purchase plans 36 149 126
Proceeds from long-term debt 494 1,105 500
Repayment of long-term debt (365) -- (12)
Increase (decrease) in loans payable (385) 484 708
Dividends paid (671) (626) (552)
Settlements of debt-related derivative contracts 279 42 9
-----------------------------
Net cash used in financing activities (1,533) (795) (231)
-----------------------------
Effect of Exchange Rate Changes on Cash (5) (2) (2)
Net Cash Provided by Discontinued Operations 130 111 45
-----------------------------
Decrease in Cash and Cash Equivalents (18) (22) (3)
Cash and Cash Equivalents at Beginning of Year 80 102 105
-----------------------------
Cash and Cash Equivalents at End of Year $ 62 $ 80 $ 102
=============================
Supplemental disclosure of cash paid for:
Interest $ 243 $ 126 $ 120
Income taxes $ 480 $ 457 $ 473
Noncash investing and financing activities:
Acquisition of businesses
Fair value of assets acquired $ -- $ -- $ 100
Cash paid -- -- 91
-----------------------------
Liabilities assumed $ -- $ -- $ 9
=============================
See accompanying Notes to Consolidated Financial Statements.
26
Consolidated Statement of Stockholders' Equity
The Gillette Company and Subsidiary Companies
Unearned Additional Other Total
Preferred ESOP Common Paid-in Earnings Treasury Comprehensive Stockholders'
(Millions, except per share amounts) Shares Compensation Stock Capital Reinvested Stock Income Equity
- -----------------------------------------------------------------------------------------------------------------------------------
Balance at December 31, 1997 $ 93 $ (17) $ 1,353 $ 309 $ 5,021 $(1,108) $ (810) $ 4,841
--------------------------------------------------------------------------------------------
Net income -- -- -- -- 1,081 -- -- 1,081
Foreign currency translation -- -- -- -- -- -- (36) (36)
Pension adjustment -- -- -- -- -- -- (27) (27)
------- -------
Other comprehensive income -- -- -- -- -- -- (63) (63)
------- -------
Comprehensive income 1,018
-------
Dividends declared (per share $.51) -- -- -- -- (573) -- -- (573)
Stock option and purchase plans
(5.3 shares) -- -- 5 125 -- -- -- 130
Conversion of Series C ESOP
preferred stock (.4 shares) (3) -- -- 1 -- 2 -- --
Purchase of Gillette treasury stock
(21.3 shares) -- -- -- -- -- (1,066) -- (1,066)
Proceeds from sale of put options -- -- -- 56 -- -- -- 56
Contingent liability of put options -- -- -- 130 -- -- -- 130
Earned ESOP compensation -- 7 -- -- -- -- -- 7
--------------------------------------------------------------------------------------------
Balance at December 31, 1998 90 (10) 1,358 621 5,529 (2,172) (873) 4,543
--------------------------------------------------------------------------------------------
Net income -- -- -- -- 1,260 -- -- 1,260
Foreign currency translation -- -- -- -- -- -- (205) (205)
Pension adjustment -- -- -- -- -- -- 17 17
------- -------
Other comprehensive income -- -- -- -- -- -- (188) (188)
------- -------
Comprehensive income 1,072
-------
Dividends declared (per share $.59) -- -- -- -- (642) -- -- (642)
Stock option and purchase plans
(5.7 shares) -- -- 6 139 -- -- -- 145
Conversion of Series C ESOP
preferred stock (.6 shares) (5) -- -- (2) -- 7 -- --
Purchase of Gillette treasury stock
(46.8 shares) -- -- -- -- -- (2,054) -- (2,054)
Proceeds from sale of put options -- -- -- 72 -- -- -- 72
Contingent liability of put options -- -- -- (82) -- -- -- (82)
Earned ESOP compensation -- 6 -- -- -- -- -- 6
--------------------------------------------------------------------------------------------
Balance at December 31, 1999 85 (4) 1,364 748 6,147 (4,219) (1,061) 3,060
--------------------------------------------------------------------------------------------
Net income -- -- -- -- 392 -- -- 392
Foreign currency translation -- -- -- -- -- -- (249) (249)
Pension adjustment -- -- -- -- -- -- (4) (4)
------- -------
Other comprehensive income -- -- -- -- -- -- (253) (253)
------- -------
Comprehensive income 139
-------
Dividends declared (per share $.65) -- -- -- -- (686) -- -- (686)
Stock option and purchase plans
(1.8 shares) -- -- 1 34 -- -- -- 35
Conversion of Series C ESOP
preferred stock (11.3 shares) (85) -- -- (92) -- 177 -- --
Purchase of Gillette treasury stock
(24.5 shares) -- -- -- -- -- (911) -- (911)
Proceeds from sale of put options -- -- -- 23 -- -- -- 23
Contingent liability of put options -- -- -- 260 -- -- -- 260
Earned ESOP compensation -- 4 -- -- -- -- -- 4
--------------------------------------------------------------------------------------------
Balance at December 31, 2000 $ -- $ -- $ 1,365 $ 973 $ 5,853 $(4,953) $(1,314) $ 1,924
============================================================================================
See accompanying Notes to Consolidated Financial Statements.
27
Notes to Consolidated Financial Statements
The Gillette Company and Subsidiary Companies
NATURE OF OPERATIONS
The Gillette Company is a global consumer products firm, with manufacturing
operations conducted at 38 facilities in 19 countries. Products are distributed
through wholesalers, retailers and agents in over 200 countries and territories.
Gillette is the world leader in male grooming, a category that includes blades,
razors and shaving preparations, and also in female grooming products, such as
wet shaving products and hair epilation devices. The Company is the world's top
seller of alkaline batteries, toothbrushes and oral care appliances.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation and Principles of Consolidation
The preparation of consolidated financial statements in conformity with
accounting principles generally accepted in the United States requires
management to make estimates and assumptions that affect the reported amounts of
assets and liabilities and disclosure of contingent assets and liabilities at
the date of the financial statements and the reported amounts of revenues and
expenses. Actual results could differ from those estimates.
The consolidated financial statements include the accounts of the Company
and its subsidiaries. Intercompany accounts and transactions are eliminated. The
Stationery Products segment is reported as a discontinued operation, as
discussed further on page 35.
Cash and Cash Equivalents
Cash and cash equivalents include cash, time deposits and all highly liquid debt
instruments with an original maturity of three months or less.
Revenue Recognition
Revenue from product sales is recognized when the goods are shipped and title
passes to the customer.
Shipping and Handling Costs
Shipping and handling costs are included in cost of sales.
Inventories
Inventories are stated at the lower of cost or market. Cost is determined on a
first-in, first-out (FIFO) basis.
Intangible Assets
Goodwill is amortized on the straight-line method, generally over a period of 40
years. The Company assesses the recoverability of goodwill by determining
whether the amortization of the goodwill balance over its remaining life can be
recovered through undiscounted future operating cash flows of the acquired
operation. If the goodwill amortization cannot be fully recovered, the amount of
possible goodwill impairment is analyzed based on projected discounted future
operating cash flows or appraised values, depending on the nature of the asset.
Other intangible assets are amortized on the straight-line method over a period
of 10 to 40 years, predominantly 40 years.
Depreciation
Depreciation is computed primarily on a straight-line basis over the estimated
useful lives of assets.
Advertising
Advertising costs are expensed in the year incurred. Advertising spending was
$608 million in 2000, compared with $580 million in 1999 and $593 million in
1998. For interim reporting purposes, advertising expenses are charged to
operations as a percentage of sales, based on estimated sales and related
advertising expense for the full year.
28
Research and Development
Research and development costs, included in selling, general and administrative
expenses, amounted to $179 million in 2000, $201 million in 1999 and $190
million in 1998.
Income Taxes
The Company reinvests unremitted earnings of foreign operations and,
accordingly, does not provide for Federal income taxes that could result from
the remittance of such earnings. These unremitted earnings amounted to $3.5
billion and $2.8 billion at December 31, 2000 and 1999, respectively.
Net Income per Common Share
Basic net income per common share is calculated by dividing net income less
dividends on preferred stock, net of tax benefits, by the weighted average
number of common shares outstanding. The calculation of fully diluted net income
per common share assumes conversion of preferred stock and stock options into
common stock, and also adjusts net income for the effect of converting the
preferred stock to common stock. At December 31, 2000, 1999 and 1998, 33
million, 35 million and 21 million shares of common stock issuable under stock
options, respectively, were not included in the calculation of fully diluted
earnings per share because their effects would have been antidilutive.
Income from continuing operations and shares used to compute net income per
share, basic and assuming full dilution, are reconciled below.
(Millions) 2000 1999 1998
- ------------------------------------------------------------------------------------
Income from Continuing Operations $ 821 $1,248 $1,073
Less: Preferred stock dividends 1 4 4
------------------------
Income from Continuing Operations, basic $ 820 $1,244 $1,069
Effect of dilutive securities:
Convertible preferred stock 2 5 5
------------------------
Income from Continuing Operations, assuming full dilution $ 822 $1,249 $1,074
========================
Common shares, basic 1,054 1,089 1,117
Effect of dilutive securities:
Convertible preferred stock 3 12 12
Stock options 6 10 15
------------------------
Common shares, assuming full dilution 1,063 1,111 1,144
========================
Reclassification of Prior Years
Prior-year financial statements have been reclassified to conform to the 2000
presentations.
EFFECT OF ACCOUNTING CHANGES
In June 1998, Statement of Financial Accounting Standards (SFAS) No. 133,
"Accounting for Derivative Instruments and Hedging Activities," was issued. The
Company adopted SFAS No. 133, as amended by SFAS No. 137 and SFAS No. 138, on
January 1, 2001. The adoption of SFAS No. 133 has not had a material impact on
the Company's financial position or overall trends in results of operations and
has not resulted in significant changes to its financial risk management
practices. However, the adoption of SFAS No. 133 could result in more pronounced
quarterly fluctuations in other income and expense.
In December 1999, the Securities and Exchange Commission issued Staff
Accounting Bulletin (SAB) No. 101, "Revenue Recognition." An amendment in June
2000 delayed the effective date until the fourth quarter of 2000. The adoption
of SAB 101 did not have a material impact on the consolidated financial
statements.
In May 2000, the Financial Accounting Standards Board's Emerging Issues
Task Force (EITF) reached a consensus on Issue No. 00-14, "Accounting for
Certain Sales Incentives." This issue addresses the recognition, measurement and
income statement classification for various types of sales incentives, including
dis-
29
counts, coupons, rebates and free products. In November 2000, the EITF revised
the transition date such that the Company must adopt EITF 00-14 no later than
the second quarter of 2001. The Company adopted the consensus in the first
quarter of 2001. The adoption of this consensus does not affect when the Company
recognizes incentives or the amount. However, adoption of this consensus will
affect the classification of revenues and expenses in the income statement. If
this standard had been adopted at December 31, 2000, including required
retroactive adjustment of prior periods, net sales would have been reduced by
$70 million in 2000, $80 million in 1999 and $64 million in 1998. Cost of sales
would have been increased by $51 million in 2000, $53 million in 1999 and $49
million in 1998. Selling, general and administrative expenses would have been
reduced by $121 million in 2000, $133 million in 1999 and $113 million in 1998.
The above reclassifications have no impact on profit from operations, net income
or earnings per share.
In July and September 2000, the EITF reached consensus on Issue No. 00-10,
"Accounting for Shipping and Handling Fees and Costs." This issue addresses the
income statement classification for shipping and handling fees and costs. The
Company adopted the consensus in the fourth quarter of 2000. The adoption of
EITF Issue No. 00-10 did not have a material impact on the consolidated
financial statements.
FOREIGN CURRENCY TRANSLATION
Net exchange gains or losses resulting from the translation of assets and
liabilities of foreign subsidiaries, except those in highly inflationary
economies, are accumulated in a separate section of stockholders' equity. Also
included are the effects of exchange rate changes on intercompany transactions
of a long-term investment nature and transactions designated as hedges of net
foreign investments. The change in accumulated foreign currency translation
adjustment in 2000 was a loss of $249 million, with the United Kingdom
accounting for $115 million of the loss. Losses in 1999 were $205 million, with
Brazil accounting for approximately half of the loss. Losses in 1998 were $36
million.
An analysis of cumulative translation adjustments follows.
(Millions) 2000 1999 1998
- ----------------------------------------------------------------------------------------
Balance at beginning of year $(1,031) $ (826) $ (790)
Translation adjustments, including the effect of hedging (216) (79) (86)
Related income tax (expense) benefit (33) (126) 50
-----------------------------
Balance at end of year $(1,280) $(1,031) $ (826)
=============================
Included in other charges in the Consolidated Statement of Income are a net
exchange gain of $8 million in 2000 and losses of $35 million and $23 million in
1999 and 1998, respectively.
SUPPLEMENTAL BALANCE SHEET INFORMATION
Receivables Reserves
(Millions) 2000 1999 1998
- --------------------------------------------------------------------------------
Balance at beginning of year $74 $79 $74
Additions, charged to profit and loss 63 50 43
Deductions, losses charged to reserves 56 55 38
-----------------------
Balance at end of year $81 $74 $79
=======================
Inventories December 31, December 31,
(Millions) 2000 1999
- --------------------------------------------------------------------------------
Raw materials and supplies $ 153 $ 190
Work in process 194 182
Finished goods 815 1,020
-----------------------
$1,162 $1,392
=======================
30
Property, Plant and Equipment December 31, December 31,
(Millions) 2000 1999
- --------------------------------------------------------------------------------
Land $ 62 $ 65
Buildings 743 713
Machinery and equipment 5,061 4,984
----------------------
5,866 5,762
Less accumulated depreciation 2,316 2,295
----------------------
$3,550 $3,467
======================
Interest on funds used to finance construction of significant additions to
tangible property and equipment is capitalized and amortized over the remaining
life of the related asset. The capitalized interest is recorded as part of the
asset to which it relates and will be amortized over the asset's estimated
useful life. During 2000, 1999 and 1998, interest cost was capitalized in the
amounts of $23 million, $13 million and $18 million, respectively.
Intangible Assets December 31, December 31,
(Millions) 2000 1999
- --------------------------------------------------------------------------------
Goodwill ($44 not subject to amortization) $1,294 $1,545
Other intangible assets 1,155 1,198
---------------------
2,449 2,743
Less accumulated amortization 875 846
---------------------
$1,574 $1,897
=====================
Other intangible assets consists primarily of capitalized amounts related to
trademarks, trade names, patents and other similar items.
Accounts Payable and Accrued Liabilities
- --------------------------------------------------------------------------------
Accounts payable $ 402 $ 513
Advertising and sales promotion 527 451
Payroll and payroll taxes 143 169
Other taxes 97 90
Dividends payable on common stock 171 157
Restructuring 240 139
Miscellaneous 766 630
-------------------
$2,346 $2,149
===================
Other Long-Term Liabilities
- --------------------------------------------------------------------------------
Pensions $ 206 $ 207
Postretirement medical 291 296
Deferred compensation 215 242
Miscellaneous 55 50
-------------------
$ 767 $ 795
===================
31
DEBT
Loans Payable December 31, December 31,
(Millions) 2000 1999
- --------------------------------------------------------------------------------
U.S. dollar Commercial Paper (6.6% and 6.0%) $ 1,452 $ 2,408
Euro Commercial Paper (5.0%) 586 --
Payable to banks (5.4% and 6.3%) 157 132
Amount reclassified as long-term debt -- (1,100)
--------------------
$ 2,195 $ 1,440
====================
Long-Term Debt
- --------------------------------------------------------------------------------
Commercial Paper $ -- $ 1,100
5.00% Notes due 2006 300 300
5.75% Notes due 2005 200 200
3.25% Euro notes due 2004 283 302
2.23% Synthetic Euro obligation due 2003 374 429
6.25% Notes due 2003 150 150
5.25% Euro notes due 2002 236 --
1.53% Synthetic Euro obligation due 2002 259 302
5.75% Notes due 2001 200 200
2.61% Synthetic Euro obligation due 2001 277 --
6.00% Notes due 2000 -- 300
8.03% Guaranteed ESOP notes due through 2000 -- 5
Other, multicurrency borrowings 2 1
--------------------
Total long-term debt 2,281 3,289
Less current portion 631 358
--------------------
Long-term portion $ 1,650 $ 2,931
====================
The Company's commercial paper program is supported by its revolving credit
facilities. The Company has a $1.4 billion revolving bank credit agreement that
expires in October 2001 and a $1.1 billion revolving bank credit agreement
expiring in December 2001, both of which may be used for general corporate
purposes. In January 2001, the $1.1 billion agreement was reduced to $550
million. Under the agreements, the Company has the option to borrow at various
interest rates, including the prime rate, and is required to pay an average
facility fee of .037% per annum. At year-end 2000 and 1999, there were no
borrowings under such agreements.
At December 31, 1999, $1.1 billion of commercial paper borrowing was
classified as long-term debt based on the Company's intention and ability to
maintain its revolving credit agreement beyond 2000.
Aggregate maturities of total long-term debt for the five years subsequent
to December 31, 2000, are $631 million in 2001, $447 million in 2002, $419
million in 2003, $283 million in 2004 and $200 million in 2005. Those maturities
include the amortization of a portion of the synthetic Euro obligations.
Unused lines of credit, including the revolving bank credit agreements,
amounted to $2.6 billion at December 31, 2000.
32
FINANCIAL INSTRUMENTS
The estimated fair values of the Company's financial instruments are summarized
below.
December 31, 2000 December 31, 1999
------------------------------ -----------------------------
Notional Carrying Fair Notional Carrying Fair
(Millions) Amount Amount Value Amount Amount Value
- ------------------------------------------------------------------------------------------
Long-term investments $ 186 $ 187 $ 188 $ 188
Long-term debt (2,281) (2,308) (3,289) (3,186)
Derivative instruments
Debt-related contracts $ 1,918 (28) (19) $ 2,196 140 93
Other currency forwards
Purchase contracts (409) 23 27 -- -- --
Sell contracts 389 (1) (5) -- -- --
Currency options -- -- -- 119 1 1
Equity contracts 39 7 7 56 1 1
Commodity contracts 26 -- (2) 29 -- 5
Notional amounts are a unit of measure specified in a derivative instrument. The
carrying amounts and fair values of the debt-related contracts include interest
receivables of $10 million and $24 million at December 31, 2000 and 1999,
respectively. The carrying amounts for cash, short-term investments,
receivables, accounts payable and accrued liabilities, and loans payable
approximate fair value because of the short maturity of these instruments. The
fair value of long-term investments is estimated based on quoted market prices.
The fair value of long-term debt, including the current portion, is estimated
based on rates currently offered to the Company for debt of the same remaining
maturities. The estimated fair values of interest rate, foreign currency, equity
and commodity contracts are calculated based on market rates. These values
represent the estimated amounts the Company would receive or pay to terminate
agreements, taking into consideration current market rates and the current
creditworthiness of the counterparties.
The Company uses derivative financial instruments to efficiently structure
its debt in the desired currencies and mix of fixed to floating interest rates.
The Company also uses derivatives to hedge transactional exchange exposure,
currency exposure from converting foreign profits into U.S. dollars,
equity-linked employee compensation and commodity exposures. All derivative
contracts hedge transactions, balances and currency exposures for periods
consistent with their underlying exposures.
The debt-related derivatives consist of interest rate swaps and forward
contracts. At December 31, 2000 and 1999, interest rate swaps converted $1.09
billion and $1.15 billion, respectively, of fixed rate debt to floating. Of the
$1.15 billion in swaps at December 31, 1999, $350 million in U.S. dollar debt
was also converted into Euro obligations of $282 million. The terms of the swaps
match the terms of the underlying debt. The floating interest rate payments
under these swaps are based on three-month LIBOR rates.
Forward contracts effectively converted $832 million and $1,046 million
U.S. dollar commercial paper borrowings in 2000 and 1999, respectively, into the
following foreign currency obligations.
December 31, December 31,
(Notional amount, millions) 2000 1999
- --------------------------------------------------------------------------------
Euro $152 $820
British pound 642 --
Other 76 178
----------------------
Total $870 $998
======================
All of the forward contracts at December 31, 2000, mature in 2001. These
forward contracts and $1.1 billion in Euro borrowings are designated as hedges
of the Company's net investment in foreign subsidiaries. Resulting currency
gains and losses on these contracts and borrowings are reported as foreign
currency translation adjustments in accumulated other comprehensive income. The
interest component of these contracts
33
is reported in interest expense over the term of the contracts. The Company's
total debt after the effect of the associated contracts - payables of $38
million at December 31, 2000, and receivables of $116 million at December 31,
1999 - follows.
December 31, 2000 December 31, 1999
----------------- -----------------
(Millions) Amount Rate Amount Rate
- --------------------------------------------------------------------------------
U.S. dollar floating rate $1,532 6.6% $2,203 6.0%
U.S. dollar fixed rate -- -- 5 8.0
Euro floating rate 1,005 4.8 1,127 3.9
Euro fixed rate 1,194 2.7 1,033 1.8
Other floating rate 783 5.6 245 3.1
------------------------------------
$4,514 5.0% $4,613 4.4%
====================================
Forward contracts entered into in order to hedge transactional currency
exposures, principally inter company balances denominated in Euro, British
pound, Yen and Canadian dollar at December 31, 2000, amounted to $409 million to
purchase foreign currencies and $389 million to sell foreign currencies. All of
these contracts mature in 2001. Gains and losses on these contracts are recorded
in earnings in other nonoperating charges and offset gains and losses on the
underlying exposure.
The Company purchases foreign currency put options to assist in protecting
its U.S. dollar earnings. The initial amounts paid are reflected in other
current assets. Changes in fair values of outstanding contracts are reflected in
profit from operations. There were no options outstanding at December 31, 2000.
The option outstanding at December 31, 1999, was denominated in Yen and expired
in December 2000.
The Company has also fixed the cost of certain employee compensation
expenses linked to its stock price by entering into equity swap and option
contracts that mature in 2002 and 2003. Outstanding contracts are stated at fair
value. Changes in fair value are reflected in profit from operations and offset
changes in the value of the underlying liabilities.
In addition, the Company enters into commodity swaps to fix the price of a
portion of certain raw materials used in the manufacturing process. The
maturities of the contracts highly correlate to the actual purchases of the
commodity, and contract values are reflected in the cost of the commodity as it
is actually purchased. The commodity swaps as of year-end 2000 mature through
December 2001.
The equity put options associated with the share repurchase program are
described separately in the Share Repurchase Program note.
Several major international financial institutions are counterparties to
the Company's financial instruments. It is Company practice to monitor the
financial standing of the counterparties and to limit the amount of exposure
with any one institution. The Company may be exposed to credit loss in the event
of nonperformance by the counterparties to these contracts, but does not
anticipate such nonperformance.
With respect to trade receivables, concentration of credit risk is
limited, due to the diverse geographic areas covered by Gillette operations. Any
possible bad debt loss has been provided for in the allowance for doubtful
accounts.
COMMITMENTS AND CONTINGENCIES
Minimum rental commitments under noncancellable leases, primarily for office and
warehouse facilities, are $84 million in 2001, $67 million in 2002, $52 million
in 2003, $44 million in 2004, $41 million in 2005 and $120 million for years
thereafter. Rental expense amounted to $113 million in 2000, $100 million in
1999 and $103 million in 1998.
The Company is subject to legal proceedings and claims arising out of its
businesses that cover a wide range of matters, including antitrust and trade
regulation, contracts, advertising, environmental issues, product liability,
patent and trademark matters and taxes. Management, after review and
consultation with counsel, considers that any liability from all of these
pending lawsuits and claims would not materially affect the consolidated
financial position, results of operations or liquidity of the Company.
34
BUSINESS COMBINATIONS AND DIVESTITURES
In 1998, the Company sold its Jafra skin care and color cosmetics business for
$200 million. The transaction did not have a material impact on financial
results.
Also during 1998, the Company acquired two businesses in the Duracell
Products segment, in South Korea and India, for an aggregate purchase price of
$100 million. These two acquisitions have been accounted for by the purchase
method of accounting. Their results of operations since acquisition, which have
been included in the Company's consolidated financial statements, have not
materially affected the consolidated financial position, results of operations
or liquidity of the Company.
Discontinued Operations
On December 29, 2000, the sale of the Stationery Products business to Newell
Rubbermaid Inc. was finalized. The sale resulted in a loss of $429 million (net
of a tax benefit of $102 million), or $.40 in net income per common share, fully
diluted. The net loss included the book loss on the transaction, the operating
loss of the segment in 2000 and other costs directly associated with the
decision to divest, including postdivestiture reorganization costs.
The Stationery Products segment is accounted for as a discontinued
operation. Accordingly, its net assets and liabilities have been segregated from
continuing operations in the accompanying consolidated balance sheet, and its
operating results are segregated and reported as discontinued operations in the
accompanying consolidated statements of income and cash flows, and related
notes. For the periods ended December 31, the results of discontinued operations
were as follows:
(Millions) 2000 1999 1998
- --------------------------------------------------------------------------------
Net sales $691 $743 $856
Income (loss) before income tax (8) 18 13
Income tax (benefit) (3) 6 5
---------------------
Income (loss) from discontinued operations $ (5) $ 12 $ 8
=====================
The assets identified as part of the disposition of the Stationery Products
business are recorded as Net Assets of Discontinued Operations; the cash flow of
the business is reported as Net Cash Provided by Discontinued Operations; and
the results of operations of the segment are reported as Income (Loss) from
Discontinued Operations, net of tax. Net Assets of Discontinued Operations
consists of the following:
(Millions) 2000 1999 1998
- --------------------------------------------------------------------------------
Net current assets $ 192 $ 509 $ 590
Property, plant and equipment,
less accumulated depreciation 6 200 187
Other net noncurrent assets and liabilities (9) 465 495
---------------------------
Net assets of discontinued operations $ 189 $1,174 $1,272
===========================
RESTRUCTURING AND ASSET IMPAIRMENT
On December 18, 2000, the Company announced a restructuring program to
significantly improve the Company's operating efficiency, streamline the supply
chain and further decrease costs. In accordance with EITF Issue 94-3, SFAS 121
and SAB 100, the Company recorded in the fourth quarter of 2000 a charge to
operating expenses of $572 million ($430 million after taxes, or $.41 in net
income per common share, fully diluted). Specific program activities include
consolidating management functions; reducing factory locations, in part through
outsourcing production of low-volume noncore products; streamlining the supply
chain via warehouse consolidation and other actions; and downsizing and
centralizing corporate functions. The program will result in the closure of
eight factories and 13 distribution centers, affecting all business segments,
and in the net reduction of approximately 2,700 employees across all business
functions, operating units and geographies. The reduction will consist of 1,430
variable manufacturing and distribution employees and 1,270
35
executive, professional and administrative staff. All employee reductions are
planned for 2001, and pretax cash outlays are estimated at approximately $235
million. The program was announced to all employees on December 18, 2000, via
the Company's internal website and bulletin boards. The severance programs being
used follow the Company's long-standing severance formulas and vary on a
country-by-country basis, depending on local statutory requirements.
The restructuring program included a write-down of approximately $125
million to the carrying amount of factories, as well as the write-off of
manufacturing, distribution and office equipment assets. Until the affected
facilities cease operations, revenue-generating activities will continue. Thus,
these assets are considered assets to be held and used under SFAS 121. Asset
disposals will be completed within 12 months. Buildings that are owned will be
sold, and equipment will be disposed of through sale or abandonment. The value
of the impaired assets was determined based on discounted cash flow analyses for
the operating period up until closure and included an estimate of residual
value.
In addition, a charge of $212 million for the write-down of goodwill
relating to underperforming brands was recognized. This write-down was
determined based upon a year-end impairment analysis necessitated by new
evidence that indicated that the carrying amounts of the assets relating to the
Thermoscan personal diagnostic appliance brand and certain national battery
brands might not be fully recovered through undiscounted future operating cash
flows. Such analysis indicated that impairment existed equivalent to the
carrying amount of the acquired goodwill for one brand in the Braun Products
segment, and the carrying amount of the acquired goodwill and identifiable
intangible assets for certain brands in the Duracell Products segment. This
analysis did not indicate impairment of the carrying amounts of any related
tangible long-lived assets associated with these underperforming brands.
Details of the restructuring program charge and the write-down of goodwill
relating to underperforming brands follow. The other benefits portion of
employee-related expenses, shown below, includes fringe benefits, outplacement
fees and special termination benefits related to pensions.
Initial 2000
(Millions) Provision Activity Balance
- --------------------------------------------------------------------------------
Employee-related expenses
Severance payments $146 $ -- $146
Other benefits 67 -- 67
Asset impairments
Property, plant and equipment 120 120 --
Goodwill 212 212 --
Contractual obligations and other 27 -- 27
--------------------------
$572 $332 $240
==========================
REORGANIZATION AND REALIGNMENT
On September 28, 1998, the Company announced a reorganization to realign its
worldwide operations. In connection with the reorganization and realignment, and
in accordance with EITF Issue 94-3 and SFAS 121, the Company recorded in the
third quarter of 1998 a charge to operating expenses of $535 million ($347
million after taxes, or $.30 in net income per common share, fully diluted). For
continuing operations, the charge to operations was $440 million ($285 million
after taxes, or $.25 in net income per common share, fully diluted). There have
been no material modifications to the scope of the original plan. The program
was essentially complete at March 31, 2000.
36
Details of the reorganization and realignment charges follow. The other
benefits portion of employee-related expenses, shown below, includes fringe
benefits, outplacement fees and special termination benefits related to
pensions.
Utilized
Initial Through Utilized Total
(Millions) Provision 1999 2000 Program
- --------------------------------------------------------------------------------
Employee-related expenses
Severance payments $265 $141 $ 68 $209
Other benefits 120 99 35 134
Asset impairments
Property, plant and equipment 122 122 26 148
Other assets 13 13 -- 13
Distributor buyout costs 15 21 10 31
----------------------------------
$535 $396 $139 $535
==================================
Severance payments were below the initial provision since the Company achieved
efficiencies versus the original plan estimates in the actual severance rates
paid to terminated employees. Asset impairment costs for property, plant and
equipment were above the initial provision for two reasons. First, as factories
were closed, there were certain instances where the Company chose not to
redeploy equipment, as planned, at other facilities; and, second, the number of
warehouse and office facility closures exceeded the original plan. The Company
achieved the objectives and scope of the original distributor buyout program,
although the effort was more costly than planned.
In accordance with EITF Issue 94-3, certain expenses related to the program,
primarily employee and equipment relocation, were not provided for, nor charged
to, the reorganization and realignment reserve. Those expenses, which were
therefore recognized as incurred, amounted to $9 million in 2000 and $61 million
in 1999. The expenses were included in selling, general and administrative
expenses. The effect of suspending depreciation for impaired assets was $9
million in 1999 and $3 million in 1998.
INCOME TAXES
Deferred income taxes are recognized for the expected tax consequences of
temporary differences by applying enacted statutory tax rates, applicable to
future years, to differences between the financial reporting basis and tax basis
of assets and liabilities.
Income before income taxes and income tax expense are summarized below.
(Millions) 2000 1999 1998
- -------------------------------------------------------------------------------
Income from continuing operations before income taxes
United States $ 664 $1,116 $1,018
Foreign 624 796 638
-------------------------
Total income before income taxes $1,288 $1,912 $1,656
=========================
Current tax expense
Federal $ 365 $ 181 $ 337
Foreign 233 244 327
State 25 22 58
Deferred tax expense
Federal (87) 134 (56)
Foreign (68) 82 (75)
State (1) 1 (8)
-------------------------
Total income tax expense $ 467 $ 664 $ 583
=========================
37
The effective tax rate increased in 2000, due primarily to the nondeductibility
of certain asset impairment charges. Excluding the impact of the restructuring
and asset impairment charge, the tax rate declined to 32.8%. The decrease was
primarily attributable to the reduction of the tax rate in Germany and the
Company's tax management strategies. A reconciliation of the statutory Federal
income tax rates to the Company's effective tax rate follows.
2000 1999 1998
- --------------------------------------------------------------------------------
Statutory Federal tax rate 35.0% 35.0% 35.0%
Goodwill amortization and asset impairments 5.0 .3 .3
Rate differential on foreign income (2.9) 2.0 1.6
Effect of foreign currency translation (.2) .5 .2
State taxes (net of Federal tax benefits) 1.2 .8 1.9
Benefit of foreign tax credits (4.2) (3.5) (3.3)
Other differences 2.4 (.3) (.4)
------------------------
Effective tax rate 36.3% 34.8% 35.3%
========================
The components of deferred tax assets and deferred tax liabilities are shown
below.
2000 1999
------------------------------ -----------------------------
Deferred Tax Deferred Tax Deferred Tax Deferred Tax
(Millions) Assets Liabilities Assets Liabilities
- --------------------------------------------------------------------------------------------------------------
Current
Advertising and sales promotion $ 21 $ -- $ 19 $ --
Benefit plans 60 -- 52 --
Discontinued operations 102 -- -- --
Restructuring and asset impairment 142 -- 67 --
Miscellaneous reserves and accruals 104 -- 62 --
Operating loss and credit carryforwards 4 -- 14 --
Other 133 -- 95 --
---------------------------------------------------------
Total current 566 $ -- 309 $ --
---------------------------------------------------------
Net current $566 $309
==== ====
Noncurrent
Benefit plans $126 $ -- $111 $ --
Intangibles -- 166 -- 195
Operating loss and credit carryforwards 27 -- 51 --
Property, plant and equipment -- 356 -- 326
Other -- 74 -- 45
---------------------------------------------------------
Total noncurrent 153 596 162 566
---------------------------------------------------------
Valuation allowance $ (7) $(19)
==== ====
Net noncurrent $450 $423
==== ====
Total
Net deferred tax assets/liabilities $116 $114
==== ====
PENSION PLANS AND OTHER RETIREE BENEFITS
The Company has various retirement programs, including defined benefit, defined
contribution and other plans, that cover most employees worldwide. Other retiree
benefits are health care and life insurance benefits provided to eligible
retired employees, principally in the United States. The components of benefit
expense for continuing operations follow.
38
Pension Benefits Other Retiree Benefits
----------------------- -----------------------
(Millions) 2000 1999 1998 2000 1999 1998
- -------------------------------------------------------------------------------------------
Components of net benefit expense:
Service cost-benefits earned $ 64 $ 67 $ 65 $ 6 $ 6 $ 6
Interest cost on benefit obligation 122 112 119 19 16 17
Estimated return on assets (171) (159) (149) (4) (4) (3)
Net amortization 5 13 7 (7) (7) (7)
Plan curtailments and other (3) (7) -- -- -- --
----------------------- -----------------------
17 26 42 14 11 13
Defined contribution plans 6 6 2 -- -- --
Other defined benefit plans 9 9 10 -- -- --
----------------------- -----------------------
Total benefit expense $ 32 $ 41 $ 54 $ 14 $ 11 $ 13
======================= =======================
The funded status of the Company's principal defined benefit and other retiree
benefit plans and the amounts recognized in the balance sheet follow.
Pension Benefits Other Retiree Benefits
---------------- ----------------------
(Millions) 2000 1999 2000 1999
- ---------------------------------------------------------------------------------------------
Change in benefit obligation:
Balance at beginning of year $1,956 $2,022 $ 261 $ 240
Benefit payments (111) (97) (17) (15)
Service and interest costs 185 179 24 22
Amendments 26 5 -- 21
Actuarial (gains) losses 78 22 (7) (1)
Plan settlements -- (93) -- --
Plan curtailments (33) (6) -- --
Divestitures (71) -- -- --
Currency translation adjustment (69) (76) (2) (6)
---------------- ----------------
Balance at end of year $1,961 $1,956 $ 259 $ 261
================ ================
Change in fair value of plan assets:
Balance at beginning of year $2,052 $1,957 $ 41 $ 36
Actual return on plan assets 42 275 (1) 5
Employer contribution 31 39 -- --
Benefit payments (91) (78) -- --
Divestitures (87) -- -- --
Plan settlements -- (91) -- --
Currency translation adjustment (69) (50) -- --
---------------- ----------------
Balance at end of year $1,878 $2,052 $ 40 $ 41
================ ================
Plan assets greater (less) than benefit obligation $ (83) $ 96 $ (219) $ (220)
Unrecognized prior service cost and
transition obligation 44 50 18 19
Unrecognized net loss (gain) 128 (71) (90) (95)
Minimum liability adjustment included in:
Intangible assets (6) (13) -- --
Stockholders' equity (34) (30) -- --
---------------- ----------------
Net prepaid (accrued) benefit cost $ 49 $ 32 $ (291) $ (296)
================ ================
39
The values at December 31 for pension plans with accumulated benefit obligations
in excess of plan assets follow.
(Millions) 2000 1999
- --------------------------------------------------------------------------------
Projected benefit obligation $513 $516
Accumulated benefit obligation 445 453
Fair value of plan assets 277 283
The weighted average assumptions used in determining related obligations of
pension benefit plans are shown below.
(Percent) 2000 1999 1998
- --------------------------------------------------------------------------------
Discount rate 7.0 6.8 6.3
Long-term rate of return on assets 9.1 9.1 8.6
Rate of compensation increases 4.7 4.7 3.9
The weighted average assumptions used in determining related obligations of
other retiree benefit plans are shown below.
(Percent) 2000 1999 1998
- --------------------------------------------------------------------------------
Discount rate 7.2 7.5 6.5
Long-term rate of return on assets 10.0 10.0 9.0
The assumed health care cost trend rate for 2001 and all subsequent years is
5.0%. A one percentage point increase in the trend rate would have increased the
accumulated postretirement benefit obligation by 18%, and interest and service
cost by 22%. A one percentage point decrease in the trend rate would have
decreased the accumulated postretirement benefit obligation by 14%, and interest
and service cost by 17%. The Employee Stock Ownership Plan (ESOP) was
established to assist Gillette employees in financing retiree medical costs.
ESOP accounts held by participants reduced the Company's obligations by $189
million and $144 million at December 31, 2000 and 1999, respectively. Account
balances are assumed to have an annual yield of 12%. A retiree health benefits
account within the Company's principal domestic pension plan also will be used
to pay these costs.
EMPLOYEE STOCK OWNERSHIP PLAN
In 1990, the Company sold to the ESOP 165,872 shares of a new issue of 8%
cumulative Series C convertible preferred stock for $100 million, or $602.875
per share.
On April 25, 2000, the trustee for the ESOP trust redeemed the Series C
preferred stock held by the trust for common stock. The redemption was made by
the trustee in order to receive the common stock dividend, which now provides a
higher return to holders than the preferred stock dividend. The redemption had
no impact on fully diluted earnings per share and closed the gap between basic
and fully diluted earnings per share. The preferred shares had a stated cost of
$84 million and were redeemed for common stock held in the Company's treasury,
at a cost of $174 million. Total stock holders' equity did not change as a
result of the redemption.
STOCK COMPENSATION PLANS AND CAPITAL STOCK
At December 31, 2000, the Company had stock-based compensation plans described
below that included the premerger plans of Duracell.
40
Stock Option Plans
Stock option plans authorize the granting of options on shares of the Company's
common stock to selected key employees, including officers, and to nonemployee
directors, at not less than the fair market value of the stock on the date of
grant. Outstanding options have seven- to 10-year terms.
Options granted prior to April 17, 1997, are exercisable one year from the
date of grant (except the Duracell options, which became exercisable upon the
merger), provided the employee optionee is still employed or the director
continues to serve. For options granted to employees after April 16, 1997,
one-third of the options become vested on each of the first three anniversaries
of the stock option award date. The plans also permit payment for options
exercised in shares of the Company's common stock (except Duracell options) and
the granting of incentive stock options.
The Company applied APB 25 and related interpretations in accounting for
its plans. Accordingly, no compensation cost has been recognized for its fixed
stock option plans in its results of operations. Had the Company recorded a
charge for the fair value of options granted consistent with SFAS 123, net
income would have been reduced by $81 million in 2000, $146 million in 1999 and
$100 million in 1998. The impact of this charge on net income per common share,
both basic and assuming full dilution, would have been $.08, $.13 and $.09 in
2000, 1999 and 1998, respectively. The weighted average fair value of options
granted was $10.58 in 2000, $14.64 in 1999 and $14.12 in 1998. The fair value of
each option grant for the Company's plans is estimated on the date of the grant
using the Black-Scholes option pricing model, with the following weighted
average assumptions.
2000 1999 1998
- --------------------------------------------------------------------------------
Risk-free interest rates 6.3% 6.1% 5.7%
Expected option lives 4.9 years 4.7 years 4.5 years
Expected volatilities 33.4% 30.4% 19.2%
Expected dividend yields 2.0% 1.3% .9%
A summary of the status of the Company's stock option plans at December 31,
2000, 1999 and 1998, follows.
2000 1999 1998
------------------------ ------------------------ ------------------------
Weighted Weighted Weighted
Average Average Average
Options Exercise Options Exercise Options Exercise
(Thousands) Price (Thousands) Price (Thousands) Price
- ---------------------------------------------------------------------------------------------------------------
Outstanding at beginning of year 51,956 $39.79 43,659 $35.49 38,828 $27.18
Granted 11,404 32.04 15,322 45.19 10,984 56.29
Exercised (2,071) 17.48 (5,745) 18.94 (5,635) 17.53
Cancelled (2,320) 47.86 (1,280) 51.52 (518) 48.59
------------------- ------------------- -------------------
Outstanding at year-end 58,969 $38.76 51,956 $39.79 43,659 $35.49
=================== =================== ===================
Options exercisable at year-end 35,067 26,962 26,321
====== ====== ======
The following table summarizes information about fixed stock options outstanding
at December 31, 2000.
Outstanding Exercisable
----------------------------------------------------- ------------------------------
Weighted Average
Range of Options Remaining Years Weighted Average Options Weighted Average
Exercise Prices (Thousands) of Contractual Life Exercise Price (Thousands) Exercise Price
- -----------------------------------------------------------------------------------------------------------------
$ 8-21 9,451 3.5 $17.28 9,451 $17.28
21-33 16,784 8.1 31.05 5,621 29.14
35-48 23,075 7.8 45.85 13,619 46.39
50-60 9,659 7.5 56.24 6,376 56.29
------------------------------------------------ -------------------------
$ 8-60 58,969 7.1 $38.76 35,067 $37.58
================================================ =========================
41
Stock Equivalent Unit Plan
Eligible Gillette employees participate in the Stock Equivalent Unit Plan, which
provides for awards of basic stock units to key employees. Each unit is treated
as equivalent to one share of the Company's common stock. However, the employee
only receives appreciation, if any, in the market value of the stock and
dividend equivalent units as dividends are paid. Appreciation on basic stock
units is limited to 100% of the original market value. Benefits accrue over
seven years, and vesting commences in the third year. Plan expense amounted to
$7 million in 2000, $10 million in 1999 and $9 million in 1998.
Share Repurchase Program
The Company has an ongoing share repurchase program that authorizes the purchase
of up to 125 million shares in the open market or in privately negotiated
transactions, depending on market conditions and other factors. From the
inception of the program through December 31, 1999, the Company repurchased 69
million shares in the open market for $3,173 million.
In 2000, the Company repurchased 25 million shares in the open market for
$911 million. The Company plans to purchase the remaining authorized shares in
the open market or in privately negotiated transactions, depending on market
conditions and other factors.
In 2000, the Company continued to sell equity put options as an
enhancement to its ongoing share repurchase program and earned $23 million in
premiums. These options provide the Company with an additional opportunity to
supplement open-market purchases of its common stock if the options expire "in
the money" (the option strike price is greater than the closing price for
Gillette common stock on the expiration date). In addition, the premiums
received are a source of funding for share purchases. The options are
exercisable only on the last day of their term. The Company, at its discretion,
may elect to settle by paying net cash or by purchasing the shares.
The put option prices were based on the market value of the Company's
stock at the date of issuance. The redemption value of the outstanding options,
which represents the options' price multiplied by the number of shares under
option, is presented in the accompanying consolidated balance sheet as
"Contingent Redemption Value of Common Stock Put Options." At December 31, 2000
and 1999, no "in the money" obligations existed on outstanding options.
Preferred Stock Purchase Rights
At December 31, 2000, the Company had 527 million preferred stock purchase
rights outstanding, representing one-half right for each share of common stock
outstanding. Each right may be exercised to purchase one ten-thousandth of a
share of junior participating preferred stock for $225. The rights will only
become exercisable, or separately transferable, on the earlier of the tenth
business day after the Company announces that a person has acquired 15% or more,
or the tenth business day after a tender offer commences that could result in
ownership of more than 15%, of the Company's common stock.
If any person acquires 15% or more of the common stock (except in an offer
for all common stock that has been approved by the Board of Directors), or in
the event of certain mergers or other transactions involving a 15% or more
stockholder, each right not owned by that person or related parties will enable
its holder to purchase, at the right's exercise price, common stock (or a
combination of common stock and other assets) having double that value. In the
event of certain merger or asset sale transactions with another party, similar
terms would apply to the purchase of that party's common stock.
The rights, which have no voting power, expire on December 14, 2005,
subject to extension. Upon approval by the Board of Directors, the rights may be
redeemed for $.01 each under certain conditions, which may change after any
person becomes a 15% stockholder.
At December 31, 2000, there were authorized 5,000,000 shares of preferred
stock without par value, of which 400,000 Series A shares were reserved for
issuance upon exercise of the rights.
42
OPERATING SEGMENTS AND RELATED INFORMATION
The following table presents certain operating segment information.
(Millions) Blades & Toiletries Duracell Oral-B Braun All Total Discontinued
2000 Razors Products Products Products Other Operations
- ---------------------------------------------------------------------------------------------------------------------------------
Net sales $ 3,407 $ 978 $ 2,577 $ 676 $ 1,657 $ -- $ 9,295 $ 691
Profit from operations 1,340 76 439 75 218 (636) 1,512 (8)
Identifiable assets 3,740 538 3,304 636 1,343 652 10,213 189
Capital expenditures 477 52 156 11 93 4 793 26
Depreciation 222 43 59 30 83 30 467 27
1999
- ---------------------------------------------------------------------------------------------------------------------------------
Net sales $ 3,167 $ 1,062 $ 2,726 $ 616 $ 1,583 $ -- $ 9,154 $ 743
Profit from operations 1,206 85 606 77 154 (41) 2,087 18
Identifiable assets 3,532 696 3,310 663 1,602 809 10,612 1,174
Capital expenditures 459 85 145 40 130 30 889 43
Depreciation 186 29 56 23 83 22 399 21
1998
- ---------------------------------------------------------------------------------------------------------------------------------
Net sales $ 3,028 $ 1,214 $ 2,576 $ 642 $ 1,740 $ -- $ 9,200 $ 856
Profit from operations 1,153 54 597 101 291 (420) 1,776 13
Identifiable assets 3,378 771 3,288 680 1,679 834 10,630 1,272
Capital expenditures 453 69 144 62 135 89 952 48
Depreciation 167 27 51 18 73 13 349 24
Each operating segment is individually managed and has separate financial
results that are reviewed by the Company's chief operating decision-makers. Each
segment contains closely related products that are unique to the particular
segment.
The Blades & Razors segment consists of blades and razors. The Toiletries
segment includes shave preparations, after-shaves and
deodorants/antiperspirants. The Duracell Products segment consists of consumer
batteries. The Oral-B Products segment primarily comprises toothbrushes and
interdental products. Included in the Braun Products segment are electric
shavers and hair epilators, as well as oral care, household, hair care and
personal diagnostic appliances. Discontinued Operations contains the Stationery
Products segment, which was sold on December 29, 2000.
Profit from operations is net sales less cost of sales and selling,
general and administrative expenses, but is not affected either by nonoperating
charges/income or by income taxes.
Nonoperating charges/income consists principally of net interest expense
and the effect of exchange.
In calculating profit from operations for individual operating segments,
substantial administrative expenses incurred at the operating level that are
common to more than one segment are allocated on a net sales basis. Certain
headquarters expenses of an operational nature also are allocated to segments.
All intercompany transactions, primarily merchandise transfers, have been
eliminated, and intersegment revenues are not significant.
The $572 million charge to profit from operations in 2000 for
restructuring and asset impairment expenses and the $440 million charge to
profit from operations in 1998 for reorganization and realignment expenses are
not assigned to the operating segments in the accompanying table, since the
elements of the charge are managed separately from the segments.
43
Had the Company allocated the charge by segment, the amounts for 2000
would have been as follows: Blades & Razors, $91 million; Toiletries, $133
million; Duracell Products, $135 million; Oral-B Products, $27 million; and
Braun Products, $186 million. The amounts for 1998 would have been as follows:
Blades & Razors, $117 million; Toiletries, $47 million; Duracell Products, $128
million; Oral-B Products, $68 million; Braun Products, $69 million; and All
Other, $11 million.
The All Other column includes items not allocated to operating segments.
Profit from operations includes all unallocated income/expense items, including
corporate headquarters expenses, as well as the $572 million charge for
restructuring and asset impairment in 2000 and the $440 million charge for
reorganization and realignment expenses in 1998. Identifiable assets includes
deferred income tax assets, nonqualified benefit trusts,
construction-in-progress costs related to Corporate Information Technology
initiatives and other financial instruments managed by the Corporate Treasury
Department. Capital expenditures is primarily related to Corporate Information
Technology initiatives.
Net sales by geographic area follow.
(Millions) 2000 1999 1998
- --------------------------------------------------------------------------------
Foreign $5,539 $5,522 $5,749
United States 3,756 3,632 3,451
------------------------------
$9,295 $9,154 $9,200
==============================
Long-lived assets at December 31 follow.
- --------------------------------------------------------------------------------
Germany $ 704 $ 655 $ 574
Other Foreign 1,145 1,178 1,169
------------------------------
Total Foreign 1,849 1,833 1,743
United States 1,701 1,634 1,542
------------------------------
$3,550 $3,467 $3,285
==============================
44
QUARTERLY FINANCIAL INFORMATION (UNAUDITED)
(Millions, except per share amounts) Three Months Ended
---------------------------------------------------
2000 March 31 June 30 September 30 December 31 Total Year
- --------------------------------------------------------------------------------------------------------
Net sales $1,907 $2,249 $2,321 $2,818 $9,295
Gross profit 1,219 1,440 1,469 1,783 5,911
Profit from operations 442 499 575 (4) 1,512
Income from continuing
operations before income taxes 389 444 524 (69) 1,288
Discontinued operations, net of tax (2) (427) -- -- (429)
Net income 258 (131) 350 (85) 392
Net income per common share,
basic (a)
Continuing operations .24 .28 .33 (.08) .78
Discontinued operations -- (.41) -- -- (.41)
Net income .24 (.13) .33 (.08) .37
Net income per common share,
assuming full dilution(a)
Continuing operations .24 .28 .33 (.08) .77
Discontinued operations -- (.41) -- -- (.40)
Net income .24 (.13) .33 (.08) .37
Dividends declared per common share .16 1/4 -- .16 1/4 .32 1/2 .65
Dividends paid per common share .14 3/4 .16 1/4 .16 1/4 .16 1/4 .63 1/2
Stock price range: (composite basis)
High 43.00 41.69 34.81 37.19 43.00
Low 28.19 30.88 27.19 27.13 27.13
1999
- --------------------------------------------------------------------------------------------------------
Net sales $1,796 $2,205 $2,354 $2,799 $9,154
Gross profit 1,164 1,382 1,476 1,740 5,762
Profit from operations 446 477 594 570 2,087
Income from continuing
operations before income taxes 411 444 545 512 1,912
Discontinued operations, net of tax 1 10 (3) 4 12
Net income 269 300 352 339 1,260
Net income per common share,
basic (a)
Continuing operations .24 .26 .33 .32 1.14
Discontinued operations -- .01 -- -- .01
Net income .24 .27 .33 .32 1.15
Net income per common share,
assuming full dilution (a)
Continuing operations .24 .25 .32 .32 1.13
Discontinued operations -- .01 -- -- .01
Net income .24 .26 .32 .32 1.14
Dividends declared per common share -- .14 3/4 .14 3/4 .29 1/2 .59
Dividends paid per common share .12 3/4 .14 3/4 .14 3/4 .14 3/4 .57
Stock price range: (composite basis)
High 64.38 60.19 48.38 45.44 64.38
Low 44.75 40.50 33.06 33.88 33.06
(a) Earnings per common share are computed independently for each of the
periods presented and, therefore, may not add up to the total for the
year.
45
Historical Financial Summary
The Gillette Company and Subsidiary Companies
(Millions, except per share amounts and employees) 2000(a) 1999 1998(b) 1997 1996(c) 1995
- --------------------------------------------------------------------------------------------------------------------------------
Summary of Operations
Net Sales (d) $ 9,295 9,154 9,200 9,138 8,783 7,972
Profit from Operations (d) $ 1,512 2,087 1,776 2,168 1,514 1,690
Income before Income Taxes
Continuing $ 1,288 1,912 1,656 2,065 1,403 1,591
Discontinued $ (531) 18 13 156 122 109
-------------------------------------------------------------------------
$ 757 1,930 1,669 2,221 1,525 1,700
Net Income
Continuing $ 821 1,248 1,073 1,327 871 1,000
Discontinued $ (429) 12 8 100 78 69
-------------------------------------------------------------------------
$ 392 1,260 1,081 1,427 949 1,069
Average Common Shares Outstanding
Basic 1,054 1,089 1,117 1,118 1,107 1,100
Assuming full dilution 1,063 1,111 1,144 1,148 1,140 1,129
Per Common Share Data
Net Income per Common Share:
Basic
Continuing $ .78 1.14 .95 1.18 .78 .91
Discontinued $ (.41) .01 .01 .09 .07 .06
-------------------------------------------------------------------------
$ .37 1.15 .96 1.27 .85 .97
Assuming full dilution
Continuing $ .77 1.13 .94 1.15 .76 .89
Discontinued $ (.40) .01 .01 .09 .07 .06
-------------------------------------------------------------------------
$ .37 1.14 .95 1.24 .83 .95
Dividends Declared per Common
Share:
Gillette $ .65 .59 .51 .43 .36 .30
Duracell $ .58 .52
Stock Price, December 31 $ 36.13 41.19 47.81 50.22 38.88 26.06
Balance Sheet Data
Net Property, Plant and Equipment (d) $ 3,550 3,467 3,285 2,918 2,404 1,882
Total Assets (d) $10,213 10,612 10,630 9,636 9,171 7,747
Long-Term Debt $ 1,650 2,931 2,256 1,476 1,490 1,048
Stockholders' Equity (d) $ 1,924 3,060 4,543 4,841 4,471 3,879
Other Information
Net Interest Expense $ 218 129 86 69 67 73
Depreciation and Amortization (d) $ 535 464 421 384 347 310
Capital Expenditures (d) $ 793 889 952 933 787 549
Employees (d) 35,200 37,600 39,800 40,500 40,400 38,100
(a) In 2000, a charge for restructuring and asset impairment expenses reduced
profit from operations and income before income taxes by $572 million, net
income by $430 million and net income per common share, both basic and
assuming full dilution, by $.41.
(b) In 1998, a charge for reorganization and realignment expenses reduced
profit from operations and income before income taxes by $440 million, net
income by $285 million, net income per common share, basic, by $.26 and
net income per common share, assuming full dilution, by $.25.
(c) In 1996, charges for merger-related costs reduced profit from operations
and income before income taxes by $413 million, net income by $283
million, net income per common share, basic, by $.26 and net income per
common share, assuming full dilution, by $.25.
(d) Represents continuing operations
46
Corporate and Stockholder Information
ANNUAL MEETING
The Annual Meeting of Stockholders will take place on Thursday, April 19, 2001,
at the John F. Kennedy Library and Museum, Columbia Point, Boston,
Massachusetts. The meeting will convene at 10 a.m.
CORPORATE HEADQUARTERS
Prudential Tower Building
Boston, Massachusetts 02199
(617) 421-7000
Via Internet: www.gillette.com
INCORPORATED
State of Delaware
COMMON STOCK
Major stock exchanges: New York, Boston, Chicago, Pacific, Frankfurt
New York Stock Exchange Symbol: G
At year-end, stockholders numbered 53,700, living in all 50 states and more than
50 countries abroad.
TRANSFER AGENT AND REGISTRAR
Fleet National Bank
c/o EquiServe L.P.
P.O. Box 43016
Providence, Rhode Island 02940-3016
(781) 575-2322
By fax: (781) 828-8813
Toll-free: (888) 218-2841
Hearing impaired: (800) 952-9245 (TTY/TDD)
Via Internet: www.equiserve.com
AUDITORS
KPMG LLP
FINANCIAL INFORMATION
The Gillette Company offers free of charge this Annual Report, which includes
Form 10-K, as well as quarterly earnings reports and other announcements
concerning financial results.
Printed copies of these materials may be requested by writing to the Office of
the Secretary; by calling toll-free (877) 788-4463 from within the United
States; or by calling (703) 386-1171 from outside the United States.
Financial information also may be reviewed, downloaded or requested in
printed form by accessing the Investors' section of www.gillette.com.
INVESTLINK - DIRECT STOCK
PURCHASE PROGRAM
InvestLink is a direct stock purchase program sponsored and administered by
Fleet National Bank, the Company's Transfer Agent. InvestLink provides an
economical, convenient way to purchase your first shares or to purchase
additional shares of Gillette common stock directly from the Company. Program
participants also may reinvest their cash dividends through InvestLink.
Interested individuals may request an investor kit by writing to the
Transfer Agent; by calling toll-free (877) 788-4463 from within the United
States; by calling (703) 386-1171 from outside the United States; or by
accessing the Investors' section of www.gillette.com.
ELECTRONIC PROXY MATERIAL DISTRIBUTION
The Company is pleased to offer its registered stockholders and participants in
its Employees' Savings Plan and ESOP the option of receiving proxy material
electronically. Registered stockholders and plan participants may authorize
electronic delivery or obtain more information at www.econsent.com/g/.
Beneficial stockholders should contact their brokerage firms to determine
the availability of electronic proxy material distribution.
Directors and Officers
DIRECTORS
Warren E. Buffett(2)
Chairman and
Chief Executive Officer,
Berkshire Hathaway Inc.
Edward F. DeGraan
President
Wilbur H. Gantz(3,4)
Former Chairman and
Chief Executive Officer,
PathoGenesis Corporation
Michael B. Gifford(1,3)
Chairman of the Board,
Danka Business Systems PLC
Carol R. Goldberg(2,4)
President,
The Avcar Group, Ltd.
Dennis F. Hightower(1,3,4)
Chief Executive Officer,
Europe Online Networks, S.A.
Herbert H. Jacobi(2,3,4)
Chairman of the Supervisory
Board, HSBC Trinkaus &
Burkhardt KGaA
James M. Kilts(2)
Chairman of the Board
Henry R. Kravis(1,2,3)
General Partner, Kohlberg Kravis
Roberts & Co., L.P.
Jorge P. Lemann(1,3)
General Partner,
GP Investimentos
Richard R. Pivirotto(2,4)
President,
Richard R. Pivirotto Co., Inc.
Marjorie M. Yang(1,3)
Chairman,
Esquel Group of Companies
Alfred M. Zeien(3)
Retired Chairman of the Board,
The Gillette Company
(1) Audit Committee
(2) Executive Committee
(3) Finance Committee
(4) Personnel Committee
Committee Chair(1,2,3,4)
OFFICERS
Chairman of the Board and
Chief Executive Officer
James M. Kilts
President and
Chief Operating Officer
Edward F. DeGraan
Executive Vice President
Jorgen Wedel
Commercial Operations,
Europe and AMEE
Senior Vice Presidents
Charles W. Cramb, Finance
Robert E. DiCenso,
Personnel and Administration
John F. Manfredi,
Corporate Affairs
Richard K. Willard, Legal
Vice Presidents
Duncan J. Adamson,
Internal Audit
Allan G. Boath,
Global Business Management
Gian U. Camuzzi, Treasurer
James P. Connolly, Legal
Michael T. Cowhig,
Global Supply Chain and
Business Development
Edward E. Guillet,
Human Resources
A. Wallace Hayes
Corporate Product Integrity
David B. Jasie, Chairman's Office
Eric A. Kraus,
Corporate Communications
Roland L. Loper, Investor Relations
Royall M. Mack, Sr., Civic Affairs
John M. McGowan, Taxation
Claudio E. Ruben, Controller
John C. Terry,
Advanced Technologies
Dieter Timmermann,
Corporate Information
Technology and Applications
Michelle E. Viotty,
New Business Development
Patent and Trademark Counsel
Donal B. Tobin
Secretary
William J. Mostyn III
Assistant Treasurer
Gail F. Sullivan
Associate General Counsels
Carol S. Fischman
Kevin Loftus
Timothy N. MacCaw
Assistant General Counsels
John B. Gatlin
Deborah Marson
Peter G.V. Mee